R. Louis (Liege, Belgium), I. Pavord (Leicester, United Kingdom)
Severe asthma fenotypes by sputum induction
A. Liapikou, E. Zervas, E. Oikonomidou, K. Samitas, A. Koutsoukou, N. Koulouris, M. Gaga (Athens, Greece)
|   |
Relative sensitivity of markers of activated eosinophils in clinical trials for asthma
P. M. Short, P. A. Williamson, L. McKinlay, D. Menzies, B. J. Lipworth (Dundee, United Kingdom)
| |
FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
T. Greulich, P. Haldar, J. Agbetile, M. Bafadhel, C. E. Brightling, A. J. Wardlaw, I. D. Pavord (Germany; Leicester, United Kingdom)
| |
Exhaled NO and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated smoking asthmatics
G. Hillas, K. Kostikas, S. Loukides, V. Bessa, G. Papadaki, E. Tseliou, V. Delimpoura, K. Mantzouranis, K. Kontogianni, S. Papiris, P. Bakakos (Athens, Greece)
| |
Sputum eosinophil count (Eos) in stable asthma: Association with central airway wall thickness (AWT)
H. Inoue, I. Ito, A. Niimi, H. Matsumoto, T. Takeda, K. Otsuka, T. Oguma, H. Nakaji, T. Tajiri, T. Iwata, M. Mishima (Japan)
| |
Current control, airway inflammation, and subsequent exacerbation in patients with asthma
N. Shiota, A. Yokoyama, Y. Haruta, N. Hattori, N. Kohno (Nankoku, Japan)
| |
Relationship between sputum analysis, methacholine challenge testing and exhaled breath condensate pH in patients with mild-to-moderate well-controlled asthma
X. Muñoz, O. Roca, S. Sanchez-Vidaurre, F. Torres, A. Villar, F. Morell, M. J. Cruz (Barcelona, Spain)
| |
Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity
R. Chaudhuri, I. Donnelly, C. Grierson, P. Lapan, J. Brady, L. Jolly, C. Weir, C. Messow, C. McSharry, M. Spears, D. Miller, N. Thomson (Glasgow, Dundee, United Kingdom; Collegeville, United States Of America)
| |
Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD)
V. Bessa, S. Loukides, G. Hillas, D. Simoes, K. Kostikas, E. Tseliou, V. Delimpoura, G. Papadaki, K. Kontogianni, S. Papiris, P. Bakakos (Athens, Greece)
| |
Usefulness of the self-powered audio device (Lung Flute) for sputum induction in patients with nonproductive cough
A. Tokuda, N. Okura, S. Furusho, M. Nishitsuji, M. Abo, N. Katamaya, M. Fujimura (Kanazawa-city, Japan)
| |
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
M. Bafadhel, S. McKenna, S. Terry, V. Mistry, C. Reid, M. McCormick, P. Rugman, M. Jenkins, P. Dodson, P. Newbold, M. Saunders, C. Brightling (Leicester, Loughborough, United Kingdom)
| |
Toll-like receptors expression in induced sputum cells of asthmatic patients
A. Crespo, J. Bellido-Casado, S. Vidal, C. Juárez, C. Granel, M. Torrejón, V. Plaza (Barcelona, Spain)
| |
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
E. Bacci, M. Latorre, A. Di Franco, L. Melosini, F. Novelli, M. Bartoli, S. Cianchetti, P. Paggiaro (Pisa, Italy)
| |
Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation
E. Dima, T. Anagnostakos, N. Koufos, A. Sotiriou, G. Papadaki, C. Roussos, N. Rovina (Athens, Greece)
| |
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
W. Wang, K. Hang, Y. Chen, C. Wang (Beijing, China)
| |
Nasal mucosa biopsy in severe astma patiens as a tool for the prediction of the inflammatory changes in lower airways
O. Ruzickova-Kirchnerova, M. Terl, I. Malkusova, V. Hrabe, P. Panzner (Pilsen, Czech Republic)
| |
The effect of DTT on concentrations of RANTES and eotaxin in sputum in COPD
B. Mallia-Milanes, U. Kolsum, T. Southworth, J. Vestbo, D. Singh (United Kingdom; Hvidovre, Denmark)
| |
Severe Asthma: Evidence of increased system entropy
I. Umar, D. Desai, C. Brightling, S. Siddiqui (Leicester, United Kingdom)
| |